Varendafil, trademarked
as Levitra, is an oral drug which may improve the flow
of blood to the penis when the flow of blood has been
altered as a result of prostate cancer treatment. Varendafil
is a medical treatment known as a PDE-5 inhibitor used
for sexual impotence that is caused biological factors.
Most prostate cancer treatments commonly cause impotence
as a side effect because some treatments shut off veins
that lead into the penis. Varendafil works by relaxing
the smooth muscles in the penis and allowing more blood
to flow in. Varendafil is not an aphrodisiac and will
not work as a potency enhancer without proper arousal.
Men who have undergone prostate cancer treatment and
who are anxious about engaging in sexual relations again
may not benefit from Varendafil. Changes in biological
function are not always responsible for impotence.
|
